What do I need to qualify for Strattera?

If you’re considering non-stimulant medication for ADHD but prefer the convenience of virtual care, you may be wondering if Strattera (atomoxetine) is available through telehealth. The good news is that as a non-controlled substance, Strattera can generally be prescribed via telehealth in all states, though specific regulations vary.

This comprehensive guide will walk you through everything you need to know about getting Strattera and other non-stimulant ADHD medications through telehealth services.

Understanding Strattera and Its Classification

Strattera (atomoxetine) is an FDA-approved medication for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in both children (6 years and older) and adults. Unlike stimulant medications such as Adderall or Ritalin, Strattera is not classified as a controlled substance by the Drug Enforcement Administration (DEA).

This non-controlled status means Strattera:

• Does not carry risk of dependence or abuse
• Can be prescribed with refills (up to 5-11 months)
• Can often be obtained in 90-day supplies
• Is not subject to the strict DEA regulations that limit stimulant prescribing

This classification difference significantly impacts how and where you can receive a Strattera prescription through telehealth.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Regulations for Non-Stimulant ADHD Medications

At the federal level, the Ryan Haight Online Pharmacy Consumer Protection Act typically restricts prescribing controlled substances without an in-person examination. However, since Strattera is not a controlled substance, it is exempt from these federal restrictions.

This means that according to federal law:

• Doctors can legally prescribe Strattera via telehealth without requiring an initial in-person visit
• Nurse practitioners and physician assistants can also prescribe non-stimulant ADHD medications via telehealth (subject to their state-specific scope of practice)
• No special DEA registration is required to prescribe Strattera virtually

While federal law provides this flexibility for non-stimulants, it’s important to understand that state regulations can add additional requirements.

State-by-State Telehealth Rules for Strattera

Although federal law permits telehealth prescribing of Strattera, states have their own telehealth regulations that providers must follow. Here’s how key states approach non-stimulant ADHD medication prescribing:

California

• Telehealth Status: Fully permitted for non-stimulant ADHD medications
• In-Person Requirement: None for Strattera
• Provider Types: MDs, DOs, NPs (with independent practice after meeting requirements), and PAs (with supervision) can all prescribe Strattera via telehealth
• Recent Changes: AB 1503 proposed in 2025 to further modernize telehealth prescribing definitions

New York

• Telehealth Status: Allowed for non-stimulant ADHD medications
• In-Person Requirement: None for non-controlled substances like Strattera
• Provider Types: Physicians, NPs (independent after 3,600 hours), and PAs (collaborative) can prescribe
• Recent Changes: NY implemented strict in-person requirements for controlled substances in 2025, but these don’t affect Strattera prescribing

Florida

• Telehealth Status: Permitted for non-stimulant ADHD medications
• In-Person Requirement: None for Strattera
• Provider Types: Physicians, NPs and PAs (with collaborative agreements) can prescribe
• Special Rules: Florida requires video (not just phone) for telehealth prescribing

Texas

• Telehealth Status: Allowed for non-stimulant ADHD medications
• In-Person Requirement: None for Strattera
• Provider Types: Physicians, NPs and PAs (with delegation) can prescribe non-stimulants
• Special Notes: Very telehealth-friendly for mental health care overall

Alabama

• Telehealth Status: Permitted with some restrictions
• In-Person Requirement: For ongoing treatment, patients must be seen in-person within 12 months (though mental health services, including ADHD treatment, are often exempt)
• Provider Types: Physicians, NPs and PAs (with supervision) can prescribe Strattera
• Special Notes: One of the stricter states for telehealth prescribing

Georgia

• Telehealth Status: Allowed for non-stimulant ADHD medications
• In-Person Requirement: None for Strattera
• Provider Types: Physicians, NPs and PAs (with supervision) can prescribe non-stimulants
• Special Notes: NPs cannot prescribe Schedule II stimulants in Georgia, making non-stimulant options especially important

New Hampshire

• Telehealth Status: Fully permitted
• In-Person Requirement: None for non-controlled substances; for controlled substances, only annual evaluations (which can be virtual)
• Provider Types: Physicians and independently practicing NPs can prescribe
• Recent Changes: SB 252 (effective August 2025) expanded telehealth prescribing flexibility

The Telehealth ADHD Evaluation Process

When seeking Strattera through telehealth, you should expect a thorough evaluation process, similar to what you’d experience in person. At Klarity Health, and with other reputable telehealth providers, the process typically involves:

1. Initial Screening: Completion of assessment questionnaires about your symptoms and medical history
2. Video Consultation: A comprehensive evaluation with a licensed provider who will:

• Review your symptoms using DSM-5 diagnostic criteria for ADHD
• Discuss your medical history, current medications, and lifestyle
• Consider potential contraindications for Strattera (like narrow-angle glaucoma or recent MAOI use)
• Rule out other conditions that might explain your symptoms

1. Diagnosis and Treatment Planning: If ADHD is confirmed, your provider will discuss treatment options, including whether Strattera is appropriate for you
2. Prescription and Monitoring: If Strattera is prescribed, you’ll typically receive the prescription electronically to your preferred pharmacy
3. Follow-Up Care: Regular check-ins to monitor progress, side effects, and adjust treatment as needed

Who Can Prescribe Strattera via Telehealth?

The types of providers who can prescribe non-stimulant ADHD medications through telehealth varies by state:

• Physicians (MDs/DOs): Can prescribe Strattera via telehealth in all states where they’re licensed
• Nurse Practitioners (NPs): Can prescribe non-stimulant ADHD medications in all states, but autonomy varies:
• In ‘independent practice’ states (like NY, NH, IL), NPs can prescribe without physician oversight
• In ‘collaborative practice’ states (like FL, TX, AL), NPs require a physician agreement
• Physician Assistants (PAs): Can prescribe non-stimulants in all states with varying levels of supervision

At Klarity Health, we connect patients with licensed providers who specialize in ADHD treatment and are fully authorized to prescribe appropriate medications in your state.

Benefits of Telehealth for Non-Stimulant ADHD Treatment

Choosing telehealth for non-stimulant ADHD treatment offers several advantages:

1. Convenience: Access care from home, eliminating travel time and waiting rooms
2. Accessibility: Especially valuable for those in rural areas or with limited mobility
3. Continuity of Care: Regular follow-ups can be easier to maintain with virtual appointments
4. Privacy: Some patients feel more comfortable discussing mental health concerns from home
5. Efficiency: Often shorter wait times for appointments compared to in-person care
6. Medication Management: Easier ongoing management of non-stimulant medications like Strattera, which require regular follow-up but not the monthly visits often needed for stimulants

Klarity Health offers these benefits while ensuring you receive the same quality of care you would expect from in-person treatment, with providers who understand the nuances of both telehealth regulations and effective ADHD management.

Strattera vs. Stimulant Medications via Telehealth

When considering telehealth options for ADHD medication, it’s helpful to understand the key differences between getting Strattera versus stimulants online:

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment